Back to Trades
HENDERSON MICHAEL THOMAS
Chief Executive OfficerDirectorCIK 0001779990
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 13
- Buy transactions
- 0
- Sell transactions
- 28
- Companies
- 2
- Active
- 2025–2026
HENDERSON MICHAEL THOMAS, Chief Executive Officer, Director, accounts for 13 disclosed filings worth $49.0M, spread across 2 companies, active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $29.1M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
13 loaded
| Jul 10 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell | $2.7M |
| Jun 24 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell | $10.6M |
| Jun 23 | SYRE Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Director | Sell | $2.0M |
| Jun 12 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell | $1.7M |
| May 29 | SYRE Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Director | Award | $582.0K |
| May 15 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell | $1.6M |
| May 8 | SYRE Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Director | Sell | $6.0M |
| Apr 20 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Exercise | $137.2K |
| Apr 10 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell | $1.7M |
| Jan 23 | SYRE Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Director | Other | $0 |
| Jan 16 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell | $1.6M |
| Jan 6 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Award | $19.2M |
| Nov 13 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell | $1.3M |
13 filings